Ignite Creation Date:
2024-05-06 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06247826
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-01-11
Brief Title:
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
Sponsor:
Groupe Francais De Pneumo-Cancerologie
Organization:
Groupe Francais De Pneumo-Cancerologie
Organization Data
Organization:
Groupe Francais De Pneumo-Cancerologie
Class:
OTHER
Study ID:
GFPC 06-2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Groupe Francais De Pneumo-Cancerologie
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None